Science

Spring Research Festival Sponsored by NICBR for First Time

A group of three men.

Left to right: Maryland State Senator Ron Young; Col. Bernard L. DeKoning, then commander, U.S. Army Medical Research Institute of Infectious Diseases (USAMRIID); and Craig W. Reynolds, Ph.D., director, Office of Scientific Operations, National Cancer Institute at Frederick.

By Melissa Porter, Staff Writer

For the past 16 years, the annual Spring Research Festival has been sponsored by NCI at Frederick and Fort Detrick to acquaint fellow researchers, students, and the community at large with the important discoveries being made at this facility to fight cancer, AIDS, and other infectious diseases.

Tags: 

Morrison Receives NIH Award for Major Ras/Raf Breakthroughs

Portrait of Debbie Morrison.

Deborah Morrison, Ph.D., Laboratory Chief, Laboratory of Cell and Developmental Signaling, Center for Cancer Research

By Ashley DeVine, Staff Writer

Deborah Morrison, Ph.D., laboratory chief, Laboratory of Cell and Developmental Signaling, Center for Cancer Research (CCR), received an NIH Director’s Award in June “for major breakthroughs in elucidating the mechanisms of Ras/Raf signaling that will be critical for diagnosis and treatment of disease,” according to the NIH Director’s Awards Ceremony brochure.

She was nominated by Ira Daar, Ph.D., senior investigator, Developmental Signal Transduction Section, Laboratory of Cell and Developmental Signaling, CCR.

Tags: 

IL-27 Found to Play Significant Role in Conferring HIV Resistance

Portrait of Lue Dai.

Lue Dai, Ph.D., postdoctoral fellow, Laboratory of Human Retrovirology, Applied and Developmental Research Directorate, SAIC-Frederick.

Platinum Highlight IconBy Nancy Parrish, Staff Writer

The human immunodeficiency virus (HIV) targets specific immune cells in the body known as macrophages because these are the cells that eliminate foreign material such as bacteria or viruses. HIV is able to reproduce and spread throughout the body if it can avoid destruction by macrophages.

Tags: 

$200,000 Grants Awarded to CCR Researchers for HIV/AIDS Studies

Anu Puri and team

Anu Puri, Ph.D., left, and her team are developing a drug delivery system that uses targeted nanoparticles containing FDA-approved anti-HIV-1 drugs. Shown with Puri are, from left: Weizao Chen, Ph.D., Dimiter Dimitrov, Ph.D., and Robert Blumenthal, Ph.D. Inset: Sanjay Malhotra, Ph.D. Their work is in collaboration with Rinti Banerjee, Ph.D., at the Indian Institute of Technology Bombay, Mumbai, India.

By Nancy Parrish, Staff Writer

Earlier this year, the Office of AIDS Research (OAR) awarded two, two-year grants of $200,000 each to Anu Puri, Ph.D., and Robert Blumenthal, Ph.D., both of the Center for Cancer Research (CCR) Nanobiology Program, and to Eric Freed, Ph.D., of the HIV Drug Resistance Program, for their research on potential new treatments for HIV.

Tags: 

Pages

Subscribe to RSS - Science